1 recruiting. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Meningocele: new trials by email Literature Review of Meningocele trials Research Report on Meningocele
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Open-label, Long-term Safety, Efficacy, and Pharmacokinetics Study of Vibegron in Pediatric Subjects 2 Years to < 18 Years of Age With NDO and on CIC Vibegron - Neurogenic Detrusor Overactivity | Phase 2 / Phase 3 | Recruiting | Urovant Sciences GmbH | 71 | 2022-10-12 | 2026-06-15 |
Meningomyelocele (1) · Myelitis, Transverse (1) · Spinal Cord Injuries (1) · Spinal Dysraphism (1)
Autoimmune Diseases (1) · Autoimmune Diseases of the Nervous System (1) · Central Nervous System Diseases (1) · Central Nervous System Infections (1) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Demyelinating Autoimmune Diseases, CNS (1) · Demyelinating Diseases (1) · Hernia (1) · Immune System Diseases (1) · Infections (1) · Myelitis (1) · Neoplasms (1) · Neoplasms by Site (1) · Nervous System Diseases (1)
Belgium (1) · Canada (1) · Croatia (1) · Denmark (1) · Georgia (1) · Jordan (1) · Latvia (1) · Lithuania (1) · Malaysia (1) · Philippines (1) · Poland (1) · Romania (1) · Serbia (1) · Slovakia (1) · Turkey (Türkiye) (1)